Concepedia

Publication | Open Access

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome

DOIFull Paper Access

70

Citations

41

References

2019

Year

Maria Consiglia Trotta, Rosa Maisto, Francesca Guida, Serena Boccella, Livio Luongo, Cornel Baltă, Giovanbattista D’Amico, Hildegard Herman, Anca Hermenean, Claudio Bucolo,
PLoS ONE

Abstract

These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA2 and inhibits local damage.

References

YearCitations

Page 1